Foam Sclerotherapy for Symptomatic Cysts in ADPKD, ADPLD and Solitary Cysts.
Journal:
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published Date:
Jun 30, 2025
Abstract
BACKGROUND: This medical center migrated from alcohol to sotradecol foam sclerotherapy (SFS) because of perceived improved efficacy in managing symptomatic kidney and liver cysts. We report technical aspects, change in short and long-term cyst volumes, patient reported outcomes, safety, and applications of the technique.